ScholarLens Back to search
2006•Medical Journal of West ChinaRequires access

Clinical efficacy of Ozagrel Sodium in the treatment of acute cerebral infarction

Chun Chen

Open publisher page 0 citations

Abstract

Objective To investigate the clinical efficacy of Ozagrel Sodium in the treatment of acute cerebral infarction.Methods 66 cases of acute cerebral infarction patients were randomly divided into two groups: the control group(32 cases) were treated with conventional therapy for 14 days;the Ozagrel Sodium group(34 cases) were added infusion of Ozagrel Sodium in addition to the conventional therapy for 14 days;the MESSS,ESS,and Bathel index were observed on the 15th day and 30th day.Results MESSS of OZagrel Sodium group was significantly lower than that of control group(P0.05),but ESS and BI were higher in Ozagrel Sodium group than control group(P0.05).The total efficacy rate in Ozagrel Sodium group on the 15th day(88.24%) and 30th day(97.06%) was significantly higher than that in control group on the 15th day(71.88%) and 30th day(81.50%)(P0.05).Conclusion Ozagrel Sodium is effective and safe in the treatment for acute cerebral infarction.

About this research paper

What this paper is about

Objective To investigate the clinical efficacy of Ozagrel Sodium in the treatment of acute cerebral infarction.Methods 66 cases of acute cerebral infarction patients were randomly divided into two groups: the control group(32 cases) were treated with conventional therapy for 14 days;the Ozagrel Sodium group(34 cases) were added infusion of Ozagrel Sodium in addition to the conventional therapy for 14 days;the MESSS,ESS,and Bathel index were observed on the 15th day and 30th day.Results MESSS of OZagrel Sodium group was significantly lower than that of control group(P0.05),but ESS and BI were higher in Ozagrel Sodium group than control group(P0.05).The total efficacy rate in Ozagrel Sodium group on the 15th day(88.24%) and 30th day(97.06%) was significantly higher than that in control group on the 15th day(71.88%) and 30th day(81.50%)(P0.05).Conclusion Ozagrel Sodium is effective and safe in the treatment for acute cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical efficacy of Ozagrel Sodium in the treatment of acute cerebral infarction.Methods 66 cases of acute cerebral infarction patients were randomly divided into two groups: the control group(32 cases) were treated with conventional therapy for 14 days;the Ozagrel Sodium group(34 cases) were added infusion of Ozagrel Sodium in addition to the conventional therapy for 14 days;the MESSS,ESS,and Bathel index were observed on the 15th day and 30th day.Results MESSS of OZagrel Sodium group was significantly lower than that of control group(P0.05),but ESS and BI were higher in Ozagrel Sodium group than control group(P0.05).The total efficacy rate in Ozagrel Sodium group on the 15th day(88.24%) and 30th day(97.06%) was significantly higher than that in control group on the 15th day(71.88%) and 30th day(81.50%)(P0.05).Conclusion Ozagrel Sodium is effective and safe in the treatment for acute cerebral infarction.

Key concepts: Medicine, Clinical efficacy, Sodium, Anesthesia, Cerebral infarction, Surgery, Internal medicine, Ischemia

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical efficacy of Ozagrel Sodium in the treatment of acute cerebral infarction — Research Paper | ScholarLens